3rd ESTRO Forum 2015 S809 and pulmonary dose. To prevent patient lifting, patients should not be pushed to perform too high amplitudes. There are no benefits regarding reproducibility, stability and P GW of changing gating method from EIG to DIBH if no visual guidance can be provided. Purpose/Objective: For volumetric modulated arc therapystereotactic body radiation therapy (VMAT-SBRT), intreatment four-dimensional cone-beam CT (4D CBCT) images are the most reliable tool for evaluating setup error and the intrafractional location of the moving target. We established and updated a novel verification system and quantitatively assessed the accuracy of our VMAT-SBRT delivery through the use of it. Materials and Methods: Five patients undergoing VMAT-SBRT at our hospital were included in this analysis. All patients had stage I non-small cell lung cancer or single lesion oligometastatic lung tumors. In the supine position, an abdominal compressor and the Elekta stereotactic body frame were used. The gross tumor volumes (GTVs) were contoured on all 10 phases of the 4D planning CT. GTVs were merged into the internal target volume (ITV). The planning target volume (PTV) was created by adding a 5 mm margin to the ITV in all directions. Fifty-five Gy in 4 fractions was prescribed to cover 95% of the PTV. Before each treatment, registration was manually performed using pre-treatment 4D CBCT with the Elekta XVI system, v4.5 or v5.0. During each fraction, in-treatment 4D CBCT images, subdivided into 10 phases were obtained and exported to Pinnacle3. The respective tumor locations during beam delivery, as determined with the 4D CBCT, were merged to form the 'actual ITV.' We could then evaluate discrepancies between the 'actual ITV' and the planning ITV. To assess the adequacy of the PTV margin, we also analyzed whether PTV covered the 'actual ITV' completely.
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1 The University of Tokyo Hospital, Department of Radiology, Tokyo, Japan Purpose/Objective: For volumetric modulated arc therapystereotactic body radiation therapy (VMAT-SBRT), intreatment four-dimensional cone-beam CT (4D CBCT) images are the most reliable tool for evaluating setup error and the intrafractional location of the moving target. We established and updated a novel verification system and quantitatively assessed the accuracy of our VMAT-SBRT delivery through the use of it. Materials and Methods: Five patients undergoing VMAT-SBRT at our hospital were included in this analysis. All patients had stage I non-small cell lung cancer or single lesion oligometastatic lung tumors. In the supine position, an abdominal compressor and the Elekta stereotactic body frame were used. The gross tumor volumes (GTVs) were contoured on all 10 phases of the 4D planning CT. GTVs were merged into the internal target volume (ITV). The planning target volume (PTV) was created by adding a 5 mm margin to the ITV in all directions. Fifty-five Gy in 4 fractions was prescribed to cover 95% of the PTV. Before each treatment, registration was manually performed using pre-treatment 4D CBCT with the Elekta XVI system, v4.5 or v5.0. During each fraction, in-treatment 4D CBCT images, subdivided into 10 phases were obtained and exported to Pinnacle3. The respective tumor locations during beam delivery, as determined with the 4D CBCT, were merged to form the 'actual ITV.' We could then evaluate discrepancies between the 'actual ITV' and the planning ITV. To assess the adequacy of the PTV margin, we also analyzed whether PTV covered the 'actual ITV' completely.
Results:
From the 5 patients, 200 4D CBCT image sets taken during VMAT-SBRT were successfully obtained and the intrafractional tumor motions during beam delivery were reasonably reproduced. Under suppressed respiration, the average amplitude of tumor motion was 4.2±3.0mm in the cranio-caudal direction. On average, the 'actual ITV' covered 87.2±5.6% of the planning ITV. In addition, the respective PTV encompassed all tumor locations in all phases. Conclusions: By using in-treatment 4D CBCT, we proved the adequacy of our ITV-PTV margin setting for VMAT-SBRT when the registration for moving lung tumors was performed using pre-treatment 4D CBCT. This result also provides valuable information prior to starting adaptive SBRT for lung tumors. Purpose/Objective: Internal intra-fraction motion during radiotherapy can result in sub-optimal treatment delivery and thus real-time adaptation strategies such as MLC tracking or gating are currently being investigated in the clinic. The goal of this study is to investigate the dosimetric effect of gated prostate cancer radiotherapy utilising kilovoltage intrafraction monitoring (KIM) in the first prospective clinical trial. In KIM, prostate position monitoring by kV flouroscopy is used to gate off the beam and re-position the patient if the prostate moves outside a predefine region. Materials and Methods: KIM is being evaluated for real-time target localisation in a 30-patient prostate radiotherapy trial. So far, one patient has completed the 40 fraction treatment, and another two patients are currently undergoing treatment. The dose delivered during each fraction with KIM was calculated using an isocenter shift dose reconstruction method. For the fractions where a gating event (with motion exceeding 3mm for 5 seconds) occurred, dose calculation was also performed for a simulated treatment scenario with no KIM gating correction. Dosimetric impact of KIM gating was evaluated through comparison of target and normal tissue dose volume statistics for the planned treatment delivery, delivery with KIM gating and delivery with no KIM correction (see Figure 1 ), for each of the gated fractions. Results: In this preliminary work, all fractions from the first patient's treatment were studied. Four fractions (out of 40) had successful KIM gating corrections. Prostate motion (mean ± standard deviation) with KIM corrections and simulated with no KIM corrections were 2.2±1.4 mm and 4.1±0.7 mm respectively. Ranges of differences between the planned and KIM corrected doses and the planned and no KIM correction doses were respectively: PTV D95% (-2. . In these fractions, PTV V105% was higher than the planned value with both KIM gating (2.98-22.18%) and with no KIM correction (17.16-27.25%). It should be noted
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